FACULTY


IMMUNOTHERAPY BRIDGE
November 28th-29th, 2018
Royal Continental Hotel, Naples, Italy


Invited Faculty


Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Fabrice Barlesi
Head of Multidisciplinary Oncology and Therapeutic Innovations at APHM, Coordinator of the Center of Early Phase Cancer Trials of Marseille CLIP2, Professor of Medicine at Aix-Marseille University, Marseille, France

Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon

Luigi Buonaguro
Unit of Molecular Biology and Viral Oncology, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Lisa H. Butterfield
Professor of Medicine, Surgery, Immunology and Clinical and Translational Science. Director, Immunologic Monitoring and Cellular Products Laboratory University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, PA

Giacomo Cartenì
Director of Medical Oncology Unit A. Cardarelli Hospital, Naples, Italy

Greg Delgoffe
Department of Immunology, University of Pittsburgh, Pittsburgh, PA

Sandra Demaria
New York University School of Medicine and NYU Langone Medical Center Alexandria Center for Life Sciences, New York, New York

Leisha Emens
Johns Hopkins University School of Medicine, Oncology, Baltimore, Maryland, US

Robert Ferris
UPMC Endowed Professor and Chief, Division of Head and Neck Surgery, Department of Otolaryngolog, University of Pittsburgh, Pennsylvania, US

Bernard A. Fox
Chief of the Laboratory of Molecular and Tumor Immunology, Oregon Health and Science University, Providence Cancer Center, Portland Medical Center, Oregon

Gordon Freeman
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, US

Jerome Galon
Research Director, National Institute of Health and Medical Research (INSERM), Paris, France

Omid Hamid
Director, Clinical Research and Immunotherapy at The Angeles Clinic and Research Institute, Los Angeles, CA

Roger Lo
Melanoma Clinic in Dermatology Member, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, California, US

Alberto Mantovani
Scientific Director IRCCS Humanitas, Professor of General Pathology, "Humanitas University", Rozzano (MI), Italy

Marco Merlano
Director of Medical Oncology Unit, S. Croce and Carle Hospital, Cuneo, Italy

Paul Nathan
Consultant Medical Oncologist, Mount Vernon Cancer Centre, Northwood, Middlesex, UK

Andrea Necchi
Medical Oncology Unit, IRCCS Foundation, National Cancer Institute, Milan, Italy

Adekunle Odunsi
Chair, Department of Gynecologic Oncology, The M. Steven Piver Professor of Gynecologic Oncology, Executive Director, Center for Immunotherapy, Roswell Park Comprehensive Cancer, Buffalo, New York, US

Hideho Okada
Cancer Immunotherapy Program, University of California San Francisco, San Francisco, CA, US

Crystal Paulos
SITC, Medical University of South Carolina, US

Sandro Pignata
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Katerina Politi
Department of Pathology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA

Igor Puzanov
Associate Professor of Medicine, Associate Director of Phase I Drug Development, Director, Melanoma Clinical Research, Director of Early Clinical Trials and Developmental Therapeutics, Director of Melanoma Program, Professor of Medicine and Oncology at Roswell Park Cancer Institute in Buffalo, New York

Kimryn Rathmel
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, US

Dirk Schadendorf
Director Clinic for Dermatology, Essen University Hospital, Essen, Germany

Kurt Schalper
Department of Pathology, Yale School of Medicine, New Haven, Connecticut. Translational Immuno-oncology Laboratory, Yale Cancer Center, New Haven, Connecticut. Medical Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, US

Stefani Spranger
The Koch Institute for Integrative Cancer Research at MIT and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, US

Giampaolo Tortora
Professor, Surgical and Medical School, Verona University, Verona, Italy

Hassane Zarour
Professor of Medicine, Immunology and Dermatology, Co-Leader, Melanoma Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pennsylvania, US

Heinz Zwierzina
Chairman of the CDDF - Cancer Drug Development Forum and Professor of Internal Medicine at Innsbruck University in Austria




For information please contact info@melanomabridge.org